
Bruck Kifle
Examiner (ID: 2332)
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1202, 1624, 1611, 1622 |
| Total Applications | 3434 |
| Issued Applications | 2601 |
| Pending Applications | 222 |
| Abandoned Applications | 651 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 895398
[patent_doc_number] => 07342007
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-03-11
[patent_title] => 'Lactams and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/549271
[patent_app_country] => US
[patent_app_date] => 2004-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30890
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/342/07342007.pdf
[firstpage_image] =>[orig_patent_app_number] => 10549271
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/549271 | Lactams and uses thereof | Mar 9, 2004 | Issued |
Array
(
[id] => 5603172
[patent_doc_number] => 20060293517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-28
[patent_title] => 'Enantiomerically pure cilazapril, process for preparation'
[patent_app_type] => utility
[patent_app_number] => 10/547821
[patent_app_country] => US
[patent_app_date] => 2004-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2182
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20060293517.pdf
[firstpage_image] =>[orig_patent_app_number] => 10547821
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/547821 | Enantiomerically pure cilazapril, process for preparation | Mar 7, 2004 | Abandoned |
Array
(
[id] => 7276390
[patent_doc_number] => 20040235841
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Cyclic compounds and compositions as protein kinase inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/794454
[patent_app_country] => US
[patent_app_date] => 2004-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9265
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20040235841.pdf
[firstpage_image] =>[orig_patent_app_number] => 10794454
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/794454 | Cyclic compounds and compositions as protein kinase inhibitors | Mar 4, 2004 | Issued |
Array
(
[id] => 5620098
[patent_doc_number] => 20060189632
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-24
[patent_title] => 'Pyrazolo[1,5-A] pyrimidine derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/547080
[patent_app_country] => US
[patent_app_date] => 2004-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 46305
[patent_no_of_claims] => 104
[patent_no_of_ind_claims] => 65
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0189/20060189632.pdf
[firstpage_image] =>[orig_patent_app_number] => 10547080
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/547080 | Pyrazolo[1,5-A] pyrimidine derivatives | Feb 29, 2004 | Issued |
Array
(
[id] => 7378303
[patent_doc_number] => 20040220178
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-04
[patent_title] => 'Substituted heterocycle fused gamma-carbolines'
[patent_app_type] => new
[patent_app_number] => 10/787941
[patent_app_country] => US
[patent_app_date] => 2004-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 75748
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20040220178.pdf
[firstpage_image] =>[orig_patent_app_number] => 10787941
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/787941 | Substituted heterocycle fused gamma-carbolines | Feb 25, 2004 | Issued |
Array
(
[id] => 7432962
[patent_doc_number] => 20040209864
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-21
[patent_title] => 'Substituted heterocycle fused gamma-carbolines'
[patent_app_type] => new
[patent_app_number] => 10/786935
[patent_app_country] => US
[patent_app_date] => 2004-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 109982
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20040209864.pdf
[firstpage_image] =>[orig_patent_app_number] => 10786935
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/786935 | Substituted heterocycle fused gamma-carbolines | Feb 24, 2004 | Issued |
Array
(
[id] => 7329939
[patent_doc_number] => 20040254159
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-16
[patent_title] => 'Heterocyclic kinase inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/785120
[patent_app_country] => US
[patent_app_date] => 2004-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 122913
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20040254159.pdf
[firstpage_image] =>[orig_patent_app_number] => 10785120
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/785120 | Heterocyclic kinase inhibitors | Feb 24, 2004 | Abandoned |
Array
(
[id] => 7138246
[patent_doc_number] => 20050182046
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-18
[patent_title] => 'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds'
[patent_app_type] => utility
[patent_app_number] => 10/777247
[patent_app_country] => US
[patent_app_date] => 2004-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 204459
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20050182046.pdf
[firstpage_image] =>[orig_patent_app_number] => 10777247
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/777247 | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds | Feb 12, 2004 | Abandoned |
Array
(
[id] => 7605313
[patent_doc_number] => 07115616
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-10-03
[patent_title] => 'Pyrimidinone compounds'
[patent_app_type] => utility
[patent_app_number] => 10/776876
[patent_app_country] => US
[patent_app_date] => 2004-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21263
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/115/07115616.pdf
[firstpage_image] =>[orig_patent_app_number] => 10776876
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/776876 | Pyrimidinone compounds | Feb 10, 2004 | Issued |
Array
(
[id] => 7239630
[patent_doc_number] => 20040157897
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-12
[patent_title] => 'Polymorphs of an epothilone analog'
[patent_app_type] => new
[patent_app_number] => 10/773819
[patent_app_country] => US
[patent_app_date] => 2004-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7565
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 435
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20040157897.pdf
[firstpage_image] =>[orig_patent_app_number] => 10773819
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/773819 | Polymorphs of an epothilone analog | Feb 5, 2004 | Issued |
Array
(
[id] => 5205661
[patent_doc_number] => 20070027143
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-01
[patent_title] => 'Novel substituted 2,3-benzodiazepine derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/771847
[patent_app_country] => US
[patent_app_date] => 2004-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35017
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20070027143.pdf
[firstpage_image] =>[orig_patent_app_number] => 10771847
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/771847 | Novel substituted 2,3-benzodiazepine derivatives | Feb 2, 2004 | Abandoned |
Array
(
[id] => 7061801
[patent_doc_number] => 20050004163
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => '3-(diarylmethylene)-8-azabicyclo[3.2.1]octane derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/767712
[patent_app_country] => US
[patent_app_date] => 2004-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25849
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20050004163.pdf
[firstpage_image] =>[orig_patent_app_number] => 10767712
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/767712 | 3-(diarylmethylene)-8-azabicyclo[3.2.1]octane derivatives | Jan 28, 2004 | Abandoned |
Array
(
[id] => 7595573
[patent_doc_number] => 07625887
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-12-01
[patent_title] => 'Receptor agonists'
[patent_app_type] => utility
[patent_app_number] => 10/543997
[patent_app_country] => US
[patent_app_date] => 2004-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 94117
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/625/07625887.pdf
[firstpage_image] =>[orig_patent_app_number] => 10543997
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/543997 | Receptor agonists | Jan 26, 2004 | Issued |
Array
(
[id] => 5649790
[patent_doc_number] => 20060135525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'Pyrazolopyrimidine compound and a process for preparing the same'
[patent_app_type] => utility
[patent_app_number] => 10/542081
[patent_app_country] => US
[patent_app_date] => 2004-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51358
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20060135525.pdf
[firstpage_image] =>[orig_patent_app_number] => 10542081
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/542081 | Pyrazolopyrimidine compound and a process for preparing the same | Jan 22, 2004 | Issued |
Array
(
[id] => 5632310
[patent_doc_number] => 20060148780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => 'Diazepanes derivatives useful as ifa inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/541183
[patent_app_country] => US
[patent_app_date] => 2004-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13648
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20060148780.pdf
[firstpage_image] =>[orig_patent_app_number] => 10541183
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/541183 | Diazepanes derivatives useful as IFA inhibitors | Jan 21, 2004 | Issued |
Array
(
[id] => 7206645
[patent_doc_number] => 20050043297
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-24
[patent_title] => 'Farnesyl dibenzodiazepinone, processes for its production and its use as a pharmaceutical'
[patent_app_type] => utility
[patent_app_number] => 10/762107
[patent_app_country] => US
[patent_app_date] => 2004-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 148
[patent_figures_cnt] => 148
[patent_no_of_words] => 34248
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10762107
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/762107 | Farnesyl dibenzodiazepinone, and processes for its production | Jan 20, 2004 | Issued |
Array
(
[id] => 7306924
[patent_doc_number] => 20040116691
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-17
[patent_title] => 'Process for cyclizing hydrolysis of an aminonitrile compound to a lactam'
[patent_app_type] => new
[patent_app_number] => 10/472473
[patent_app_country] => US
[patent_app_date] => 2004-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3086
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0116/20040116691.pdf
[firstpage_image] =>[orig_patent_app_number] => 10472473
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/472473 | Process for cyclizing hydrolysis of an aminonitrile compound to a lactam | Jan 19, 2004 | Abandoned |
| 10/758264 | Process for the preparation and purification of thiol-containing maytansinoids | Jan 15, 2004 | Abandoned |
Array
(
[id] => 5711017
[patent_doc_number] => 20060052362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'Skeletal muscle protecting agent'
[patent_app_type] => utility
[patent_app_number] => 10/542322
[patent_app_country] => US
[patent_app_date] => 2004-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22662
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20060052362.pdf
[firstpage_image] =>[orig_patent_app_number] => 10542322
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/542322 | Skeletal muscle protecting agent | Jan 14, 2004 | Abandoned |
Array
(
[id] => 7288496
[patent_doc_number] => 20040147576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-29
[patent_title] => 'Platelet ADP receptor inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/759396
[patent_app_country] => US
[patent_app_date] => 2004-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7838
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20040147576.pdf
[firstpage_image] =>[orig_patent_app_number] => 10759396
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/759396 | Platelet ADP receptor inhibitors | Jan 14, 2004 | Issued |